Urinary leukotriene E4 concentration in patients with bronchial asthma and intolerance of non steroids anti-inflammatory drugs before and after oral aspirin challenge;Stȩżenie leukotrienów E4 w moczu chorych na astmȩ oskrzelowa̧ z nietolerancja̧ NLPZ w wywiadzie przed doustna̧ prowokacja̧ aspiryna̧ i po prowokacji

Polskie Archiwum Medycyny Wewnetrznej

Volumn 110, Issue 2, 2003, Pages 849-854

  Rubinsztajn, Renata ^a   Wrońska, Jolanta ^a   Chazan, Ryszarda ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Aspirin asthma; Leukotrienes

Indexed keywords

ACETYLSALICYLIC ACID; ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONIC ACID; ICOSANOID; LEUKOTRIENE C4; LEUKOTRIENE D4; LEUKOTRIENE E4; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ANALYTICAL EQUIPMENT; ARACHIDONIC ACID METABOLISM; ARTICLE; ASTHMA; CLINICAL ARTICLE; DISEASE DURATION; DRUG HYPERSENSITIVITY; DRUG SENSITIVITY; ENZYME IMMUNOASSAY; FAMILY HISTORY; FEMALE; HUMAN; INFLAMMATION; MALE; NOSE POLYP; PATHOGENESIS; PROVOCATION TEST; SKIN TEST; URINARY EXCRETION; INHALATION TEST; METHODOLOGY; MIDDLE AGED; URINE;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; ASTHMA; BRONCHIAL PROVOCATION TESTS; DRUG HYPERSENSITIVITY; FEMALE; HUMANS; LEUKOTRIENE E4; MALE; MIDDLE AGED;

EID: 18344415053     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Henderson W.: The role of leukotrienes in inflammation. Ann. Intern. Med., 1994, 121, 684.
2. Szczeklik A., Gryglewski R., Czerniawska-Mysik G.: Relationship of inhibition of prostaglandin biosynthesis by analgesics to astma attacs in aspirin-sensitive patients. BMJ 1975, 1, 67.
3. Szczeklik A., Gryglewski R., Czerniawska-Mysik G.: Clinical patterns of hypersensitivity to nonsteroidal anti-inflammatory drugs and their pathogenesis. J. Allergy Clin. Immunol., 1977, 60, 276.
4. Szczeklik A.: The cyklooxygenase theory of aspirin-induced asthma. Eur. Respir J., 1990, 3, 588.
5. Lee T., Christie P.: Leukotrienes and aspirin induced asthma. Thorax, 1993, 48, 1189.
6. Cowburn A., Sladek K., Soja J. i wsp.: Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma. J. Clin. Invest., 1998, 101, 1.
7. Sanak K., Pierzchalska M., Bazan-Socha S. i wsp.: Enhanced expression of the leukotriene C4 synthase due to overactive transcription of an allelic variant associated with aspirin-intolerant asthma. Am. J. Respir. Cell. Mol. Biol., 2000, 23, 290.
8. Sanak K., Simon H, Szczeklik A.: Leukotriene C4 synthase promoter polymorphism and risk of aspirin-induced asthma. Lancet, 1997, 350, 1599.
9. Maltby N., Taylor I., Black P i wsp.: Leukotriene C elimination and metabolism in man. J. Alergy Clin. Immunol., 1990, 85, 3.
10. Kulus M.: Leki przeciwleukotrienowe. Pneumonologia i Alergologia Polska, 2002, 40 (suppl. 1), 72.
11. Marphy R., Hammarström S., Samuelsson B.: Leukotriene C: a slow-reacting substance from murine mastocytoma cells. Proc. Natl. Acad. Sci. USA, 1079, 76, 4275.
12. Check W.: Prostaglandyn research captures. Nobel price. JAMA, 1982, 248, 2212.
13. Suzuki N., Hishinuma T., Abe F. i wsp.: Difference in urinary LTE4 and 11-dehydro-TXB2 excretion in asthmatic patients. Prostaglandins and other lipid mediators 2001, 62, 395.
14. Ferreri N., Howland W., Stevenson D. i wsp: Relase of leukotrienes, prostaglandins and histamine into nasal secretion of aspirin-sensitive asthmatics during reaction to aspirin. Amm. Rev. Respir. Dis., 1988, 137, 847.
15. Oosaki R., Mizushima Y., Mita H. i wsp.: Urinary leukotriene E4 and 11-dehydrotromboxane B2 in patients with aspirin-sensitive asthma. Allergy, 1997, 52, 470.
16. Niżankowska E., Bestyńska Krypel A., Ćmiel A. i wsp.: Oral and bronchial provocation test with aspirin for diagnosis of aspirin-induced asthma. Eur. Respir. J., 2000, 15, 863.
17. Daffern P., Muilenburg D., Hugli T. i wsp.: Association of urinary leukotriene E4 excretion during aspirin challenges with severity of respiratory response. J. Allergy Clin. Immunol., 1999, 104, 559.
18. Christie P., Schmitz-Schumann M., Spur B. i wsp.: Airway responsiveness to leukotriene C4 (LTC), leukotriene E4 (LTE4) and histamine in aspirin-sensitive asthmatic subjects. Eur. Respir J., 1993, 6, 1468.
19. Nasser S., Patel M., Bell G. i wsp.: The effect of aspirin desensitization on urinary leukotriene E4 concentration in aspirin-sensitive asthma. Am. J. Respir. Crit Care Med., 1955, 151, 1326.
20. Yanfei G., Tieying S., Hongsheng Z.: The relationship between eosinophilis activated T lymphocyte, leukotriene and the exercise-induced asthma. Zhonghua Jie He He Hu Xi Za Zhi, 2001, 24, 360.
21. Tagami H., Mizugaki M. Hishinuma T. i wsp.: Increased urinary leukotriene E4 excretion in patients with atopic dermatitis. British Journal of Dermatology, 2001, 144, 19.
22. Rubinsztajn R.: Montelukast - postȩp w leczeniu pacjentów z astma̧ oskrzelowa̧. Problemy Terapii Monitorowanej 2001, 12, 137.
23. GINA 2002.